LY3540378
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY3540378, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF) [Phase 2]